Vanessa Research reports that the European Patent Office has issued a patent for the formulation of an oral anti-diarrheal treatment for babies and young children with Microvillus Inclusion Disease. The U.S. and world patents are pending.

The formula, Shylicine™, has been developed at the company’s Hamden facility over the past two years, and is now being prepared for investigational production in Hungary.